Cancer Screening: Patient and Population Strategies

Dorothy S Lane; Robert A Smith

doi:10.1016/j.mcna.2023.06.002

Cancer Screening: Patient and Population Strategies

Med Clin North Am. 2023 Nov;107(6):989-999. doi: 10.1016/j.mcna.2023.06.002. Epub 2023 Jul 14.

Authors

Dorothy S Lane¹, Robert A Smith²

Affiliations

¹ Department of Family, Population and Preventive Medicine, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794-8222, USA. Electronic address: dorothy.lane@stonybrookmedicine.edu.
² Early Cancer Detection Science Department, American Cancer Society.

PMID: 37806730
DOI: 10.1016/j.mcna.2023.06.002

Abstract

Although cancer has been the second leading cause of death for close to 100 years, progress has been made in reducing cancer mortality and morbidity, with the adoption of high-quality screening tests and treatment advances delivered at earlier stages of diagnosis. To achieve the high cancer screening rates demonstrated by some practices, proven effective strategies need to be broadly adopted at both the patient and population levels. Factors affecting cancer screening test completion and approaches to improvement are described both generally and for breast, lung, cervical, colorectal, and prostate cancers. Closing the racial disparity gap is a critical component of reaching cancer screening and prevention goals.

Keywords: Breast; Cancer; Cervix; Colorectal; Lung; Primary care; Prostate; Screening.

Publication types

Review

MeSH terms

Breast Neoplasms*
Colorectal Neoplasms* / diagnosis
Colorectal Neoplasms* / prevention & control
Early Detection of Cancer
Humans
Male
Mammography
Prostatic Neoplasms* / diagnosis
Prostatic Neoplasms* / prevention & control